- In the
management of Parkinson's disease, due to the
chronic nature of Parkinson's
disease (PD), a broad-based
program is
needed that
includes patient...
- the
brand name Myopridin, is a
muscle relaxant that is used as an
antiparkinsonian and
anticholinergic drug. It was
approved for
medical use in the UK...
-
disease for just a
short period of time.
Clinical drugs used as an
antiparkinsonian agent such as
Trihexyphenidyl are
known to
create tactile hallucinations...
- Pronoran,
Trivastal ****, Trastal, Trivastan,
Clarium and others) is an
antiparkinsonian agent and
piperazine derivative which acts as a D2 and D3 receptor...
-
Tropatepine (brand name Lepticur) is an
anticholinergic used as an
antiparkinsonian agent.
Tropatepine can be
synthesized from 3-chlorotropane (1). A Grignard...
- for
prophylaxis against the
influenza virus A in 1966. In 1968, its
antiparkinsonian effects were
serendipitously discovered. In 1973, the Food and Drug...
-
Levodopa was
first synthesized and
isolated in the
early 1910s. The
antiparkinsonian effects of
levodopa were
discovered in the 1950s and 1960s. Following...
-
reuptake inhibitor activity Budipine t-Bu Ph H Ph
Antiparkinsonian agent Prodipine iPr Ph H Ph
Antiparkinsonian agent Ketobemidone Me 3-HO–Ph H –COEt Opioid...
-
gastrointestinal symptoms ****ociated with the use of
dopamine agonist antiparkinsonian agents. In the
United Kingdom,
domperidone is only
indicated for the...
- PMID 19636034. Syvälahti EK,
Kunelius R, Laurén L (February 1988). "Effects of
antiparkinsonian drugs on
muscarinic receptor binding in rat brain,
heart and lung"...
